Lexeo Therapeutics, Inc. (LXEO) Preferred Shares (2022)
Lexeo Therapeutics' Preferred Shares history spans 1 years, with the latest figure at $185.6 million for Q4 2022.
- For Q4 2022, Preferred Shares changed N/A year-over-year to $185.6 million; the TTM value through Dec 2022 reached $185.6 million, changed N/A, while the annual FY2022 figure was $185.6 million, N/A changed from the prior year.
- Preferred Shares for Q4 2022 was $185.6 million at Lexeo Therapeutics.
- Across five years, Preferred Shares topped out at $185.6 million in Q4 2022 and bottomed at $185.6 million in Q4 2022.